|
IQSEC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.70493999999133E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62811999999679E-05 |
| Normal-vs-Stage2 |
6.627400E-01 |
| Normal-vs-Stage3 |
5.68349999952034E-07 |
| Normal-vs-Stage4 |
3.67500000000298E-05 |
| Stage1-vs-Stage2 |
5.974300E-04 |
| Stage1-vs-Stage3 |
2.591600E-01 |
| Stage1-vs-Stage4 |
4.847200E-01 |
| Stage2-vs-Stage3 |
1.630450E-04 |
| Stage2-vs-Stage4 |
2.241300E-03 |
| Stage3-vs-Stage4 |
8.861800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.03820000006006E-07 |
| Normal-vs-AfricanAmerican |
1.260470E-02 |
| Normal-vs-Asian |
1.538360E-03 |
| Caucasian-vs-AfricanAmerican |
5.102000E-01 |
| Caucasian-vs-Asian |
5.253800E-01 |
| AfricanAmerican-vs-Asian |
8.797800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.556100E-03 |
| Normal-vs-Female |
2.09870000000834E-06 |
| Male-vs-Female |
1.577430E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.13039999999998E-05 |
| Normal-vs-Age(41-60Yrs) |
1.84950000003958E-06 |
| Normal-vs-Age(61-80Yrs) |
2.710400E-02 |
| Normal-vs-Age(81-100Yrs) |
5.590200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.343400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.309500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.166600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.742800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.658200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.012400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.097800E-02 |
| Classical-VS-Follicular |
1.725760E-02 |
| Classical-VS-Other |
9.531700E-02 |
| Classical-VS-Normal |
3.7671999999489E-06 |
| Tall-VS-Follicular |
1.763330E-04 |
| Tall-VS-Other |
6.265600E-01 |
| Tall-VS-Normal |
9.32429999878082E-08 |
| Follicular-VS-Other |
3.497600E-02 |
| Follicular-VS-Normal |
5.170200E-02 |
| Other-VS-Normal |
6.828900E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.411500E-04 |
| Normal-vs-N1 |
5.57469626016882E-11 |
| N0-vs-N1 |
1.67690999999248E-05 |
|
|
